Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1

American Journal of Pathology

Volumn 166, Issue 5, 2005, Pages 1419-1426

  Mansur, Daniel S ^a   Kroon, Erna G ^a   Nogueira, Maurício L ^c   Arantes, Rosa M E ^a   Rodrigues, Soraia C O ^a,b   Akira, Shizuo ^d   Gazzinelli, Ricardo T ^a,b   Campos, Marco A ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYTOKINE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLINDNESS; CHO CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA VIRUS; GENETIC TRANSFECTION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION SENSITIVITY; LETHALITY; MORTALITY; MOUSE; MOUTH INFECTION; NEUROPATHOLOGY; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RECURRENT INFECTION; REPORTER GENE; VIRUS ISOLATION; VIRUS PURIFICATION; VIRUS RESISTANCE; WILD TYPE;

EID: 17844387847     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62359-0     Document Type: Article

References (32)

1. Roizman B, Whitley RJ: The nine ages of herpes simplex virus. Herpes 2001, 8:23-27
2. Boivin G, Coulombe Z, Rivest S: Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci 2002, 16:29-43
3. Hirsh HH, Bossart W: Two-centre study comparing DNA preparation and PCR amplification protocols for herpes simplex virus detection in cerebrospinal fluids of patients with suspected herpes simplex encephalitis. J Med Virol 1999, 57:31-35
4. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of Gram negative and Gram positive bacterial cell wall components. Immunity 1999, 11:443-451
5. Campos MA, Almeida IC, Takeuchi O, Akira S, Paganini E, Procópio DO, Travassos LR, Smith JA, Golenbock DT, Gazzinelli RT: Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001, 167:416-423
6. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 1998, 282:2085-2088
7. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT: Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000, 105:497-504
8. Campos MA, Rosinha GMS, Almeida IC, Salgueiro XS, Jarvis BW, Splitter GA, Bruna-Romero O, Gazzinelli RT, Oliveira SC: The role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun 2004, 72:176-186
9. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NFKB by Toll-like receptor 3. Nature 2001, 413:432-438
10. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A: The innate immune response to bacterial flagelin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103
11. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745
12. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21:335-376
13. Yamamoto M, Takeda K, Akira S: TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 2004, 40:861-868
14. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M: Herpes simplex virus type 1 (HSV-1) activates murine natural interferon-producing cells (IPC) through Toll-like receptor 9. Blood 2004, 103:1433-1437
15. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401
16. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101:1315-1320
17. Lund J, Saio A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198:513-520
18. Lundberg P, Welander P, Han X, Cantin E. Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 2003, 77:11158-11169
19. Joklik WK: The purification of four strains of poxvirus. Virology 1962, 18:9-18
20. Nogueira ML, Siquelra RC, Freitas N, Amorim JB, Bonjardim CA, Ferreira PC, Orefice F, Kroon EG: Detection of herpesvirus DNA by the polymerase chain reaction (PCP) in vitreous samples from patients with necrotising retinitis. J Clin Pathol 2001, 54:103-106
21. Campos MA, Kroon EG: Critical period of irreversible block of vaccinia virus replication. Rev Bras Microbiol 1993, 24:104-110
22. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevlk T, Ingalls RR, Radolf JD, Golenbock DT: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999, 274:33419-33425
23. Delude RL, Yoshimura A, Ingalis RR, Golenbock DT: Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. J Immunol 1998, 161:3001-3009
24. Schmidt, N J: Cell culture techniques for diagnostic virology. Diagnostic Procedures for Viral, Rickettsial and Chiamydial Infections. Edited by Lennette EH, Schmidt, NJ. Washington. American Public Health Association, Inc., 1979, p 100
25. Bowle A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O'Neil LAJ: A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc Natl Acad Sci USA 2000, 97:10162-10175
26. Smith PS, Wolcott RM, Chervenak R, Jennings SR: Control of acute Herpes simples virus infection: T-cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology 1994, 202:76-88
27. Liu T, Khanna KM, Carriere BN, Hendricks RL: Gamma interferon can prevent Herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 2001, 75:11178-11184
28. Sainz Jr B, Halford WP: Alpha/beta interferon and gamma interferon synergize to inhibit the replication of Herpes simplex virus type 1. J Virol 2002, 76:11541-11550
29. Vollstedt S, Arnold S, Schwerdel C, Franchini M, Alber Gottfried, Di Santo JP, Ackermann M, Suter M: Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against Herpes simplex virus type 1. J Virol 2004, 78:3846-3850
30. Keadle TL, Usui N, Laycock KA, Kumano Y, Pepose JS, Stuart PM: Cytokine expression in murine corneas during recurrent herpetic stromal keratitis. Ocul Immunol Inflamm 2001, 9:193-205
31. Whitley RJ: Herpes simplex viruses. Fields Virology. Edited by Knipe DM, Howley PM. Philadelphia, Lippincott Williams and Wilkins, 2001, pp 2461-2510
32. Minagawa H, Hashimoto K, Yanagl Y: Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. J Gen Virol 2004, 85:343-347